TITLE:
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

CONDITION:
Osteoarthritis

INTERVENTION:
MK0663, etoricoxib

SUMMARY:

      The purpose of this study is to compare the gastrointestinal tolerability of an
      investigational drug to an approved drug in the treatment of osteoarthritis during one year
      treatment period.
    

DETAILED DESCRIPTION:

      The duration of treatment is 12 months.
    

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Osteoarthritis of the knee, hip, hand or spine which requires the use of medications
             for pain relief

        Exclusion Criteria:

          -  Known allergies to the study drugs
      
